אינטראטקט 100 גרםליטר
kamada ltd, israel - immunoglobulins, normal human - תמיסה לאינפוזיה - immunoglobulins, normal human 100 mg/ml - immunoglobulins, normal human, for intravascular adm.
ארומזין
pfizer pfe pharmaceuticals israel ltd - exemestane - טבליות מצופות - exemestane 25 mg - exemestane - exemestane - aromasin is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. aromasin is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies. aromasin is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.
בריפלקס pn 250
csl behring ltd., israel - coagulation factor ii (human); coagulation factor ix (human- rfixfc); coagulation factor vii (human); coagulation factor x (human); protein c; protein s antigen - אבקה וממס להכנת תמיסה להזרקה - coagulation factor ii (human) 200 - 480 iu; coagulation factor vii (human) 100 - 250 iu; coagulation factor ix (human- rfixfc) 200 - 310 iu; coagulation factor x (human) 220 - 600 iu; protein c 150 - 450 iu; protein s antigen 120 - 380 iu - coagulation factor ix, ii, vii and x in combination - coagulation factor ix, ii, vii and x in combination - -treatment and perioperative prophylaxis of bleedings in acquired deficiency of the prothrombin complex coagulation factors, such as deficiency caused by treatment with vitamin k antagonists, or in case of overdose of vitamin k antagonists, when rapid correction of the deficiency is required.
טימוגלובולין
sanofi israel ltd - immunoglobulin rabbit anti-human thymocyte - אבקה להכנת תמיסה מרוכזת לעירוי - immunoglobulin rabbit anti-human thymocyte 25 mg/vial - antithymocyte immunoglobulin (rabbit) - antithymocyte immunoglobulin (rabbit) - immunosuppression in transplantation: prevention and treatment of graft rejection. treatment of acute graft versus host disease (gvhd). hematology treatment of aplastic anemia.
אוקטאפלקס iu 500
dover medical & scientific equipment ltd, israel - coagulation factor ii (human); coagulation factor ix (human- rfixfc); coagulation factor vii (human); coagulation factor x (human); protein; protein c; protein s antigen - אבקה וממס להכנת תמיסה לאינפוזיה - coagulation factor ix (human- rfixfc) 25 iu/ml; coagulation factor ii (human) 14 - 38 iu/ml; coagulation factor vii (human) 9 - 24 iu/ml; coagulation factor x (human) 18 - 30 iu/ml; protein 13 - 41 mg/ml; protein c 13 - 31 iu/ml; protein s antigen 12 - 32 iu/ml - coagulation factor ix, ii, vii and x in combination
בריפלקס pn 500
csl behring ltd., israel - coagulation factor ii (human); coagulation factor ix (human- rfixfc); coagulation factor vii (human); coagulation factor x (human); protein c; protein s antigen - אבקה וממס להכנת תמיסה להזרקה - coagulation factor ii (human) 400 - 960 iu; coagulation factor vii (human) 200 - 500 iu; coagulation factor ix (human- rfixfc) 400 - 620 iu; coagulation factor x (human) 440 - 1200 iu; protein c 300 - 900 iu; protein s antigen 240 - 760 iu - coagulation factor ix, ii, vii and x in combination
אלפרוליקס 1000 יבל
megapharm ltd - coagulation factor ix (human- rfixfc) - אבקה וממס להכנת תמיסה להזרקה - coagulation factor ix (human- rfixfc) 1000 iu/vial - coagulation factor ix
אלפרוליקס 2000 יבל
megapharm ltd - coagulation factor ix (human- rfixfc) - אבקה וממס להכנת תמיסה להזרקה - coagulation factor ix (human- rfixfc) 2000 iu/vial - coagulation factor ix
אלפרוליקס 250 יבל
megapharm ltd - coagulation factor ix (human- rfixfc) - אבקה וממס להכנת תמיסה להזרקה - coagulation factor ix (human- rfixfc) 250 iu/vial - coagulation factor ix
אלפרוליקס 3000 יבל
megapharm ltd - coagulation factor ix (human- rfixfc) - אבקה וממס להכנת תמיסה להזרקה - coagulation factor ix (human- rfixfc) 3000 iu/vial - coagulation factor ix